This inventor holds 1 USPTO granted patent. Top assignee: Celgene Quanticel Research, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Daniel E Lopes De Menezes
Introduction
Daniel E Lopes De Menezes is a notable inventor based in Berkeley, CA. He has made significant contributions to the field of medicine, particularly in the treatment of leukemia and myelodysplastic syndrome. His innovative approach combines existing therapies to enhance patient outcomes.
Latest Patents
One of his key patents is titled "Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other compounds for treating leukemia or myelodysplastic syndrome." This patent outlines methods for using 5-azacytidine in conjunction with additional agents to treat diseases and disorders, including acute myeloid leukemia (AML). He holds 1 patent in this area.
Career Highlights
Daniel is currently associated with Celgene Quanticel Research, Inc., where he continues to explore innovative solutions in cancer treatment. His work is characterized by a commitment to improving therapeutic strategies for patients facing challenging diagnoses.
Collaborations
Throughout his career, Daniel has collaborated with esteemed colleagues, including C L Beach and Shelonitda Rose. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Daniel E Lopes De Menezes exemplifies the spirit of innovation in the medical field. His contributions to cancer treatment through his patented methods demonstrate the impact of combining existing therapies for improved patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile